About William Koster
Form D filings for OcuTerra Therapeutics from 2019 to 2024 list William Koster as director.
William Koster first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name William Koster in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Koster works with at each company, as listed on that company's latest Form D.
OcuTerra Therapeutics, Inc. · Form D/A, Feb 22, 2024
KB
Kerrie Brady
Chief Executive Officer and director
DE
D. Edwards
Executive officer
RS
Robin Steele
Director
DT
David Tanzer
Executive officer
BF
Bruce Failing
Director
BR
Barbara Ryan
Director
BS
Brenton Saunders
Director
RR
Robert Ruffolo
Director
WS
William Steinkrauss
Executive officer